In-hospital formula supplementation and breastfeeding initiation in infants born to women with pregestational diabetes mellitus

2019 ◽  
Vol 12 (3) ◽  
pp. 285-293 ◽  
Author(s):  
L. Cordero ◽  
M.R. Stenger ◽  
M.B. Landon ◽  
C.A. Nankervis
Keyword(s):  
Diabetes Mellitus ◽  
Breastfeeding Initiation ◽  
Pregestational Diabetes

Breastfeeding initiation among women with chronic hypertension superimposed on pregestational diabetes mellitus

2021 ◽  
pp. 1-7
Author(s):  
L. Cordero ◽  
M.R. Stenger ◽  
M.B. Landon ◽  
C.A. Nankervis
Keyword(s):  
Diabetes Mellitus ◽  
Retrospective Cohort ◽  
Chronic Hypertension ◽  
Breastfeeding Initiation ◽  
Neonatal Hypoglycemia ◽  
Pregestational Diabetes ◽  
Targeted Interventions ◽  
Expressed Breast Milk ◽  
Nicu Admission ◽  
Exclusive Or

OBJECTIVE: To compare breastfeeding (BF) initiation among 317 women with chronic hypertension (CHTN) and 106 women with CHTN superimposed on pregestational diabetes (CHTN-DM) who intended exclusive or partial BF. METHODS: Retrospective cohort study of women who delivered at≥34 weeks of gestation. At discharge, exclusive BF was defined by direct BF or BF complemented with expressed breast milk (EBM), partial BF was defined by formula supplementation. RESULTS: CHTN and CHTN-DM groups were similar in prior BF experience (42 vs 52%), intention to BF exclusively (89 vs 79%) and intention to partially BF (11 vs 21%). Women in the CHTN group were younger (31 vs 33y), more likely primiparous (44 vs 27%), and who delivered vaginally (59 vs 36%) at term (85 vs 75%). Women in the CHTN-DM group had higher repeat cesarean rates (32 vs 18%), preterm birth (25 vs 15%), neonatal hypoglycemia (42 vs 14%) and NICU admission (38 vs 16%). At discharge, exclusive BF rates among CHTN was higher (48 vs 19%), while rates of partial BF (34 vs 44%) and FF (18 vs 37%) were lower than in the CHTN-DM group. BF initiation (exclusive plus partial BF) occurred in 82%of CHTN and in 63%of CHTN-DM. CONCLUSION: Although intention to BF was similar, BF initiation rates were higher for the CHTN compared to the CHTN-DM group. Exclusive BF was low in the CHTN and even lower in the CHTN-DM group signaling the need for targeted interventions if BF initiation rates are to be improved.

scholarly journals Can navigation and interpregnancy care improve outcomes in patients with pregestational diabetes mellitus (PGDM)?

2022 ◽  
Vol 226 (1) ◽  
pp. S647-S648
Author(s):  
Kaila Krishnamoorthy ◽  
Kimone Powell ◽  
Shauna F. Williams ◽  
Lisa Gittens-Williams ◽  
Joseph J. Apuzzio
Keyword(s):  
Diabetes Mellitus ◽  
Pregestational Diabetes

Breastfeeding initiation in women with gestational diabetes mellitus

2013 ◽  
Vol 6 (4) ◽  
pp. 303-310 ◽  
Author(s):  
L. Cordero ◽  
S.G. Gabbe ◽  
M.B. Landon ◽  
C.A. Nankervis
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Breastfeeding Initiation

scholarly journals Effect of Different Insulin Therapies on Obstetric-Fetal Outcomes

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Cristina López-Tinoco ◽  
José Luis Jiménez-Blázquez ◽  
Laura Larrán-Escandón ◽  
María del Mar Roca-Rodríguez ◽  
Fernando Bugatto ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Infusion ◽  
Insulin Analogues ◽  
Fetal Outcomes ◽  
Pregestational Diabetes ◽  
Acting Insulin ◽  
Short Acting Insulin ◽  
Neutral Protamine Hagedorn ◽  
The Mean

AbstractTo evaluate the effectiveness of the different insulin therapies on obstetrics-fetal outcomes in women with pregestational diabetes mellitus. We enrolled 147 pregnant women with pre-existing type 1 or 2 diabetes mellitus. Clinical and biochemical parameters were analysed in relation to obstetric and fetal outcomes. 14.2% received treatment with Neutral Protamine Hagedorn insulin and short-acting insulin analogues; 19% with premixed human insulin; 40.1% with insulin glargine and lispro, 6.2% with detemir and aspart and 20% with continuous subcutaneous insulin infusion. All 5 types of treatment achieved a reduction of the mean HbA1c during pregnancy (p = 0.01). Pre-pregnancy care was carried out for 48% of patients. We found no statistically significant differences between the different insulin therapies and the obstetric-fetal outcomes. In conclusión, the different insulin therapies used in patients with pregestational diabetes mellitus does not seem to affect obstetric-fetal outcomes.

Sign in / Sign up

Export Citation Format

Share Document